Literature DB >> 12135824

Patient focus groups about nurse-led shared care for the chronically ill.

Irmgard M J G Eijkelberg1, Ingrid M Mur-Veeman, Cor Spreeuwenberg, Renelle L W Koppers.   

Abstract

Traditional care offered to chronically ill people does not succeed in bridging the gap between primary and secondary care in a way that suits chronic patients' needs. So-called nurse-led shared care may offer a solution, in which a specialised nurse practitioner plays a co-ordinating role at patient level. In this article two nurse-led shared care models for patients with diabetes mellitus type 2 and chronic obstructive pulmonary disease (COPD) are looked upon through the patient's eye. Joint focus groups are conducted in which patients judge the models according to their experiences and indicate the importance they attribute to quality issues. Most of them experience the shared care models as positive and prefer them compared to traditional care. The main quality aspect concerns the provision of information, although its performance needs improvement. The outcome indicates that the qualitative method of patient focus groups should become standard procedure in evaluating the shared care, supported by quantitative means.

Entities:  

Mesh:

Year:  2002        PMID: 12135824     DOI: 10.1016/s0738-3991(02)00006-x

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  2 in total

Review 1.  Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis.

Authors:  S Winsor; A Smith; M Vanstone; M Giacomini; F K Brundisini; D DeJean
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01

Review 2.  Underlying mechanisms of complex interventions addressing the care of older adults with multimorbidity: a realist review.

Authors:  Monika Kastner; Leigh Hayden; Geoff Wong; Yonda Lai; Julie Makarski; Victoria Treister; Joyce Chan; Julianne H Lee; Noah M Ivers; Jayna Holroyd-Leduc; Sharon E Straus
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.